Research Analysts Offer Predictions for Joint Corp’s Q2 2020 Earnings (NASDAQ:JYNT)

Joint Corp (NASDAQ:JYNT) – Investment analysts at B. Riley issued their Q2 2020 earnings estimates for shares of Joint in a report issued on Tuesday, November 5th. B. Riley analyst J. Van. Sinderen expects that the company will post earnings per share of $0.05 for the quarter. B. Riley has a “Buy” rating and a $23.00 price objective on the stock. B. Riley also issued estimates for Joint’s Q3 2020 earnings at $0.06 EPS.

Joint (NASDAQ:JYNT) last announced its earnings results on Thursday, November 7th. The company reported $0.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.03 by $0.01. The company had revenue of $12.73 million for the quarter, compared to analyst estimates of $11.60 million. Joint had a return on equity of 114.93% and a net margin of 5.38%.

Other equities research analysts have also recently issued reports about the stock. DA Davidson reaffirmed a “buy” rating on shares of Joint in a report on Monday, November 4th. ValuEngine cut shares of Joint from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. BidaskClub raised shares of Joint from a “buy” rating to a “strong-buy” rating in a report on Thursday, September 19th. Zacks Investment Research raised shares of Joint from a “hold” rating to a “buy” rating and set a $23.00 price target for the company in a report on Wednesday, October 30th. Finally, Maxim Group reissued a “buy” rating and set a $25.00 price target on shares of Joint in a report on Friday. One analyst has rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $24.17.

NASDAQ:JYNT opened at $19.15 on Friday. The company has a fifty day simple moving average of $18.82 and a two-hundred day simple moving average of $18.09. Joint has a 52 week low of $6.51 and a 52 week high of $21.80. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 3.33. The company has a market cap of $275.64 million, a price-to-earnings ratio of 478.75 and a beta of 1.01.

A number of hedge funds and other institutional investors have recently bought and sold shares of JYNT. Marshall Wace North America L.P. purchased a new position in Joint during the first quarter worth about $47,000. Strs Ohio purchased a new position in Joint during the second quarter worth about $63,000. Skylands Capital LLC raised its holdings in Joint by 4.4% during the second quarter. Skylands Capital LLC now owns 550,701 shares of the company’s stock worth $10,023,000 after purchasing an additional 23,051 shares in the last quarter. Wedge Capital Management L L P NC purchased a new position in Joint during the second quarter worth about $719,000. Finally, Wells Fargo & Company MN purchased a new position in Joint during the second quarter worth about $227,000. 64.45% of the stock is owned by hedge funds and other institutional investors.

About Joint

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates through two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and the sale of regional developer rights. As of March 07, 2019, the company operated 450 clinics in the United States.

Recommended Story: What are the benefits of buying treasury bonds?

Earnings History and Estimates for Joint (NASDAQ:JYNT)

Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.